ASML's Q2 Report Looms With a $26.5 Billion Demand Signal and an Unresolved Washington Question

ASML shares fall 3.3% ahead of earnings call, but analysts raise targets and SK Hynix's record IPO signals strong chip demand. US export compliance concerns loom.

The Dutch lithography giant enters its quarterly earnings week in an unusual spot: the stock shed 3.3% over the past five sessions, yet analysts are raising price targets and a key customer just pulled off the largest foreign IPO in Nasdaq history. For ASML, the gap between market nerves and underlying fundamentals has rarely felt wider.

Shares closed Friday at €1,574.20, down 0.51% on the day and 3.3% for the week. The dip came even as SK Hynix, one of ASML's most important clients for extreme ultraviolet (EUV) lithography systems, made its Wall Street debut with a 13% first-day pop to $168.01 from a $149 IPO price. The South Korean memory chip maker raised $26.5 billion in the offering, and its CEO Chey Tae-won told CNBC that surging demand from AI agents and robots would require "a lot of memory chips" — exactly the kind of chips that require ASML's machines to produce. SK Hynix has already invested roughly 11.9 trillion won this year in EUV equipment to expand capacity.

That vote of confidence stands in sharp contrast to the political headwind blowing from Washington. In mid-June, US Commerce Secretary Howard Lutnick warned ASML's management that one of the company's state-of-the-art EUV machines may have ended up in China, which would violate US export controls. Bloomberg reported the concerns on June 19, citing unnamed sources. ASML has firmly denied the allegation, arguing that it has never shipped an EUV machine — or any component designed specifically for one — to China. The company points to the sheer impracticality: each machine is roughly the size of a school bus, weighs around 180 tons, and requires permanent on-site maintenance. US officials claim they have evidence of EUV components and transport gear reaching China, but they have not made that evidence public — nor, as far as is known, presented it to ASML. The standoff remains unresolved as CEO Christophe Fouquet and CFO Roger Dassen prepare to field questions on the company's export compliance for the first time in a formal earnings call on Wednesday.

That call, set for July 15 before the Amsterdam market opens, will focus squarely on the order book. Investors are zeroing in on net bookings, the pace of EUV deliveries, and the ramp of the new High-NA EUV platform, especially after reports that TSMC has delayed its adoption due to high costs. ASML has raised its own guidance multiple times this year: for 2026 it now expects total revenue between €36 billion and €40 billion, with a gross margin of 51% to 53%. Bank of America believes the order book for 2027 is already essentially sold out, a scenario that could shift investor attention to the profit potential for 2028.

Analysts are positioning for strong numbers. Bernstein's David Dai lifted his price target from $1,971 to $2,623 and reiterated an Outperform rating, forecasting 91 EUV system deliveries in 2027 and 113 in 2028. Deutsche Bank, Morgan Stanley and Susquehanna have also raised their targets in recent trading days, all citing the ongoing flow of orders tied to AI infrastructure.

Technically, the stock sits 6.53% above its 50-day moving average of €1,477.77 and a hefty 34.94% above the 200-day line. At the same time, it remains 9.94% below the record high of €1,748.00 reached on June 30. The 30-day annualized volatility of 64.27% suggests the market is braced for a sharp move either way, while the Relative Strength Index at 51.1 points to neutral positioning — leaving the tape wide open to the earnings catalyst.

Wednesday's report will be closely followed by TSMC's own quarterly numbers, providing a second read on whether the High-NA adoption story is on track. For ASML, the earnings verdict will be decided on two fronts simultaneously: the raw order figures and the management's handling of the China controversy. After a 59% year-to-date gain and a 129% surge over the past twelve months, the stock has priced in a lot of optimism. The question is whether the numbers and the narrative can justify it.